Global push to make Life-Saving leukemia transplants safer for kids
NCT ID NCT07297914
Summary
This international study aims to improve stem cell transplants for children and young adults with high-risk or relapsed acute lymphoblastic leukemia (ALL). Researchers will test different approaches to reduce serious complications like graft-versus-host disease while maintaining the transplant's ability to fight leukemia. The study will enroll up to 1,000 patients across multiple countries to compare treatment strategies within a coordinated framework.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAFT -VERSUS-HOST-DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Goethe-Universität
Frankfurt, Germany
-
HUS-Yhtymae (HUS Helsinki University Hospital)
Helsinki, Finland
-
IRCCS Ospedale Pediatrico Bambino Gesù
Roma, RM, 00165, Italy
-
Rigshopsitalet, University Hospital
Copenhagen, Denmark
-
Robert- Debré Academic Hospital
Paris, France
-
St'Anna Children Hospital
Vienna, Austria
-
University Hospital
Oslo, Norway
-
University Hospital Motol
Prague, Czechia
-
University of Medical Sciences
Poznan, Poland
Conditions
Explore the condition pages connected to this study.